251 related articles for article (PubMed ID: 25107641)
41. The regulatory role of miRNAs on VDR in breast cancer.
Singh T; Adams BD
Transcription; 2017 Aug; 8(4):232-241. PubMed ID: 28598255
[TBL] [Abstract][Full Text] [Related]
42. Triple-negative breast cancer: what is known about it?
Ferguson LL; Curran B; Martinez M; Mancuso P
Clin J Oncol Nurs; 2014 Feb; 18(1):E6-E11. PubMed ID: 24476739
[TBL] [Abstract][Full Text] [Related]
43. Search of MicroRNAs Regulating the Receptor Status of Breast Cancer In Silico and Experimental Confirmation of Their Expression in Tumors.
Chernyi VS; Tarasova PV; Kozlov VV; Saik OV; Kushlinskii NE; Gulyaeva LF
Bull Exp Biol Med; 2017 Sep; 163(5):655-659. PubMed ID: 28944429
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs and triple negative breast cancer.
D'Ippolito E; Iorio MV
Int J Mol Sci; 2013 Nov; 14(11):22202-20. PubMed ID: 24284394
[TBL] [Abstract][Full Text] [Related]
45. Deep Sequencing Reveals a MicroRNA Expression Signature in Triple-Negative Breast Cancer.
Chang YY; Lai LC; Tsai MH; Chuang EY
Methods Mol Biol; 2018; 1699():99-111. PubMed ID: 29086372
[TBL] [Abstract][Full Text] [Related]
46. Triple-negative breast cancer: investigating potential molecular therapeutic target.
Papa A; Caruso D; Tomao S; Rossi L; Zaccarelli E; Tomao F
Expert Opin Ther Targets; 2015 Jan; 19(1):55-75. PubMed ID: 25307277
[TBL] [Abstract][Full Text] [Related]
47. Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer.
Giltnane JM; Balko JM
Discov Med; 2014 May; 17(95):275-83. PubMed ID: 24882719
[TBL] [Abstract][Full Text] [Related]
48. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.
Denkert C; Liedtke C; Tutt A; von Minckwitz G
Lancet; 2017 Jun; 389(10087):2430-2442. PubMed ID: 27939063
[TBL] [Abstract][Full Text] [Related]
49. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.
Kong X; Liu W; Kong Y
J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134
[TBL] [Abstract][Full Text] [Related]
50. Regulatory gene linked to progression and relapse of triple-negative breast cancer.
Brown E
Pharmacogenomics; 2014 Apr; 15(6):733. PubMed ID: 25022026
[No Abstract] [Full Text] [Related]
51. [Triple Negative Breast Cancer].
Navrátil J; Fabian P; Palácová M; Petráková K; Vyzula R; Svoboda M
Klin Onkol; 2015; 28(6):405-15. PubMed ID: 26673990
[TBL] [Abstract][Full Text] [Related]
52. [Triple negative breast cancer: a difficult disease to diagnose and treat].
Zaharia M; Gómez H
Rev Peru Med Exp Salud Publica; 2013; 30(4):649-56. PubMed ID: 24448944
[TBL] [Abstract][Full Text] [Related]
53. Response to: Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'.
Shin VY; Kwong A
Br J Cancer; 2016 May; 114(10):e6. PubMed ID: 27100733
[No Abstract] [Full Text] [Related]
54. Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.
Gregório AC; Lacerda M; Figueiredo P; Simões S; Dias S; Moreira JN
Pathol Oncol Res; 2018 Oct; 24(4):701-716. PubMed ID: 28913723
[TBL] [Abstract][Full Text] [Related]
55. Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics.
Bernier J; Poortmans PM
Breast; 2016 Aug; 28():148-55. PubMed ID: 27318170
[TBL] [Abstract][Full Text] [Related]
56. Triple negative breast cancer: the role of metabolic pathways.
Dean SJ; Rhodes A
Malays J Pathol; 2014 Dec; 36(3):155-62. PubMed ID: 25500513
[TBL] [Abstract][Full Text] [Related]
57. Re: Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
Bakinde N; Gbolahan O; Ibraheem A
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25265941
[No Abstract] [Full Text] [Related]
58. Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.
Martignetti L; Tesson B; Almeida A; Zinovyev A; Tucker GC; Dubois T; Barillot E
BMC Genomics; 2015; 16(Suppl 6):S4. PubMed ID: 26046581
[TBL] [Abstract][Full Text] [Related]
59. The Impact of microRNAs in Breast Cancer Angiogenesis and Progression.
Kontomanolis EN; Fasoulakis Z; Papamanolis V; Koliantzaki S; Dimopoulos G; Kambas NJ
Microrna; 2019; 8(2):101-109. PubMed ID: 30332982
[TBL] [Abstract][Full Text] [Related]
60. A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway.
Pardo I; Fagundes PB; Oliveira RS; Campregher PV
Einstein (Sao Paulo); 2024; 22():eRW0552. PubMed ID: 38324848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
